Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea flag South Korea · Delayed Price · Currency is KRW
30,000
+1,100 (3.81%)
At close: Jun 5, 2025, 3:30 PM KST

Daihan Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
176,400154,056163,170183,600172,200197,700
Upgrade
Market Cap Growth
-10.78%-5.59%-11.13%6.62%-12.90%4.11%
Upgrade
Enterprise Value
69,42680,16760,09396,028117,564155,174
Upgrade
Last Close Price
30000.0026200.0026805.7728765.6226404.5529892.12
Upgrade
PE Ratio
5.324.565.747.367.6011.38
Upgrade
PS Ratio
0.860.750.831.001.001.19
Upgrade
PB Ratio
0.630.560.660.820.851.09
Upgrade
P/TBV Ratio
0.630.560.660.820.851.09
Upgrade
P/FCF Ratio
8.787.769.289.015.996.99
Upgrade
P/OCF Ratio
5.004.324.206.334.245.88
Upgrade
EV/Sales Ratio
0.340.390.310.520.690.93
Upgrade
EV/EBITDA Ratio
1.561.771.352.282.903.76
Upgrade
EV/EBIT Ratio
1.872.111.682.914.045.18
Upgrade
EV/FCF Ratio
3.464.043.424.714.095.49
Upgrade
Debt / Equity Ratio
00-0.030.120.16
Upgrade
Debt / EBITDA Ratio
0.000.00-0.150.580.70
Upgrade
Debt / FCF Ratio
0.000.00-0.320.821.02
Upgrade
Asset Turnover
0.650.660.690.670.650.66
Upgrade
Inventory Turnover
4.815.365.385.465.225.03
Upgrade
Quick Ratio
2.992.583.283.042.722.47
Upgrade
Current Ratio
3.663.223.873.653.203.10
Upgrade
Return on Equity (ROE)
12.50%12.89%12.01%11.66%11.79%9.97%
Upgrade
Return on Assets (ROA)
7.35%7.69%7.83%7.50%6.91%7.49%
Upgrade
Return on Capital (ROIC)
8.77%9.08%9.32%8.99%8.31%9.15%
Upgrade
Return on Capital Employed (ROCE)
13.00%13.50%14.20%14.10%12.80%14.00%
Upgrade
Earnings Yield
18.79%21.91%17.42%13.59%13.16%8.79%
Upgrade
FCF Yield
11.38%12.88%10.77%11.10%16.71%14.30%
Upgrade
Payout Ratio
13.06%12.82%13.20%8.45%9.30%12.13%
Upgrade
Buyback Yield / Dilution
--1.75%0.25%--
Upgrade
Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.